PhD (Specialist in Genetic Toxicology; Univ. Autónoma de Barcelona) and Bachelor of Pharmacy (Univ. Central de las Villas, Cuba). Current position: Senior Toxicologist & Nonclinical Safety Adviser, at Ferrer Advanced Biotherapeutics. Ferrer Internacional. Previous positions: Pharmacovigilance Officer/Senior Nonclinical Toxicologist (Ferrer); Medical Adviser. Dermatology Area (Ferrer); Senior Toxicologist. Head of In vivo Toxicology Group (Ferrer); Senior Nonclinical Toxicology Study Director (RCC-CIDA s.a.l.). Senior Toxicologist/Nonclinical Safety with more than 15 years of experience working in the design and management of several fields of nonclinical toxicology and safety issues to support the efficacy/safety in the R&D in New Development Projects with the aim to obtain new medicinal products. Co-author of over 12 peer-review of scientific publications. Invited Speaker at 20 Scientific Events in the last 10 years at international congress. Expert of European Commission: Sixth and Seven Framework Programme. Area Preclinical Toxicology and Mutagenesis. Expert Member Panel in Innovative Medicines Initiative (IMI)-Scientific Panel to evaluate the proposals for the IMI2 9th Call: topic on ‘Next generation of electronic translational safety–NexGETS. Member of Editorial Board of scientific journals and several Organizing Committee of Scientific Congress. Member of Jury several doctoral theses (Univ. Autónoma de Barcelona. Current interests: Open innovation & Collaborative Bio-Research. Advanced Therapies. Neuropharmacology. Ophthalmology. Molecular diagnostics and other Therapeutic areas.
Senior Toxicologist & Nonclinical Safety Adviser
1.Completed Master degree (M. Pharm.) in 1972 – got first job- P. Banerjee- Mihijam, India 2 Joined as a Lecturer – Department of Pharmaceutics, BHU – Varanasi, India (1973-1975); Joined PhD program as a full time student – Under Prof. Dr. S. Ghosal (1975-1978). 3 Came to USA – on March 14, 1983- Worked for about one year at Phoenix Lab. then joined Super pharm ( Generic – Solid dosage -worked for about three years) – 4 Joined Quad Pharmaceutical, Indianapolis, Indiana (Generic – Injectable- worked for about three years) 5 Joined GAF chemical, NJ (Worked for three years – Pharmaceutical Excipient ) – Got an opportunity to work with Dr. Herbert Lieberman-one of the author of world famous book- Pharmaceutical Dosage forms. 6 Joined Mova Pharmaceutical, Puerto Rico (Worked for about two years – Contract Manufacturing, Involved in process –improvement, Scale up activities, improve quality issues etc. – 7 Joined Forest Laboratory (worked for about 18 years Brand- Solid dosage, liquid, & Injectable) - When joined – company was only few million dollar company, then after few years, become billion dollar company. In this process, got an opportunity to learn more in different areas & Involved in process improvement, Scale up activities, Technology Transfer, CMC, stability, CTM, Training, and Quality etc. Comments from my supervisors: 8. Independent Pharmaceutical consultant (June 2013 – Present) ? Jaiswal DMRK ? Meda Pharmaceutical ? Achlis Associates ? Lachman Consultants
Drug Development, CTM (Clinical trial Materials) Monitoring stability studies
Academician Victor S. Dorodny is the Founder and Chief Scientist of the Naturopathic Evidence-based Wellness (NEW™) Institute in Malibu, California. Prof. Dorodny is dedicated to education of wellness consumers, and implementation his principles of complementary convergence of Naturopathy and traditional Medical Science to achieve and maintain Natural Health. He is the former Chief Medical Officer of the Malibu Medical Reserve Corpse (MMRC)—a volunteer organization under the guidance of the US Surgeon General dedicated to assisting authorities in a form of Medical Disaster Assistance Teams. (MDAT) He is the past Vice-President, of ICN Eastern Europe, a Division of ICN Pharmaceuticals, Inc, Costa Mesa-based global pharmaceutical company and has many years of experience in pharmaceutical, vitamins and nutraceutical manufacturing. As practicing/consulting physician, academician and technologist with 30 years of clinical and consulting experience he is an expert on Anesthesiology and Pain Management, Rehabilitation, and Multi-disciplinary approach to the management of chronic disease states. Academicia Dorodny’s areas of expertise encompass traditional medical practice and naturopathy with a focus on nutrition, botanical medicine, homeopathy, hydrotherapy, physical manipulation, pharmacology and psychology. Dorodny was founder and president of Health PRO Worldwide, Inc., a Health & Wellness consulting company in Pasadena, California since 1993. Since 1995 he is the Founder & Chairman of TRIPAC, National Health & Wellness Advocacy dedicated to ongoing transformation of health consumers and provider of health & wellness products and services, and team approach to utilization of traditional medicine and naturopathic strategies for optimal health. He has served as consultant to the Economic and Social Council of the United Nations; Technical Advisor to the United States Department of Justice and FBI; past president of the National Association of Managed Care Physicians (NAMCP). He is a Board Member of Association of Medical Directors of Information Systems (AMDIS); Board member of the IPA Association of America (TIPAAA), National Managed Health Care Congress/Health Information Technologies (NMHCC/HIT); California State Pharmacy Partnership; Health Care Advisory Committee-Assembly; California Legislature and US Congress. Member(A) of the Scientific Advisory Board of the US Food and Drug Administration (US FDA). A native of Odessa, USSR Prof. Dorodny received his M.D. and M.P.H. degrees from N.I. Pirogov Medical Institute in Odessa, USSR in 1975; He completed his residency in Anesthesiology at the USC-Los Angeles County Medical Center in 1982. Graduate USC Executive Management Institute in Health Care in 1993 and received Ph.D. in Health Informatics from International Informatization Academy in 1997. Prof. Dorodny is Board Certified by the American Academy of Pain Management, and is an Associate in Medicine of the American College of Legal Medicine (ACLM). Prof. Dorodny has made significant contributions to major mass media publications, peer review journals and trade publications. He has authored numerous monographs and books, and his editorial board appointments include Managed Healthcare, and The Medical Reporter. He is the only physician in the USA on the editorial boards of US Pharmacist and Information Security Journal. He is a frequently invited keynote presenter at national and international conferences, and featured guest on national TV and radio. Prof. Dorodny is an Active Academician with the International Informatization Academy (IIA) and a frequent participant in projects at the Institute for Alternative Futures, National Association of Consulting Pharmacist, and Joint Commission for Accreditation of Hospital Organizations (JCAHO), National Pharmaceutical Council, and US Food and Drug Administration.
Dr. M.R. Jayapal received Ph. D. in Synthetic Organic Electrochemistry from Sri Venkateswara University in 2010 and done M. Sc. in Organic Chemistry from Sri Venkateswara University in 2005. He started as an Assistant Professor in Chemistry in Institute of Aeronautical Engineering in 2011 and as an Assistant Professor in Chemistry and Head at Narasaraopeta Engineering college in 2013. After that joined as a Research scientist in National University of Cordoba in Argentina from 2015.to 2018 .Presently working as a Talented Young scientist in YanCheng Institute of Technology in China.His interested research areas are Synthesis and Bio assay of Novel Hetero cycles, A study on biologically potent Hetero cycles, Synthesis of Nano particles and Synthesis ,characterization and Electrochemical behavior of chalcones ,Isoxazolins,Pyrazolins,Drugs and Pesticides of using D.C.Polarography,Differential pulse polarography,Cyclic Voltammetry, sensitive differential pulse adsorptive stripping voltammetric method ,Electro organic synthesis etc. He has been collaborated research work with South Africa and India various researcher published over 20 research publications and 2 text book and communicated research papers are about 3 and working as an Organizing committee member and Keynote speaker in many conferences
Dr. Barkat Ali Khan: Was born on 20 September 1982 in, Bannu, Khyber Pakhtunkhwa, Pakistan. He completed his B. Pharm. in 2005 from Gomal University D.I Khan, M. Phil. and PhD (Pharmaceutics) in 2010 and 2013 respectively from the Islamia University of Bahawalpur under the supervision of renowned professor Dr. Navid Akhtar. He is serving as a Lecturer in the department of Pharmaceutics at faculty of Pharmacy, Gomal University D.I Khan, Pakistan, since January 2012. He also served the school of pharmacy, Kampala international university Uganda; east Africa for one year. He has more than 100 publications in national and international journals. His research interest is in the area of cosmetics, skin preparations, novel drug delivery systems such as nanoparticles, microparticles and liposomes and their design, preparation optimization and evaluation. He is the managing editor of Gomal University Journal of Research. He is serving as Editorial Board Member and reviewer for many reputed journals. He received scholarship for his master and PhD studies from the higher education commission (HEC) of Pakistan. He was granted travel expenses to present his research papers at Thailand, Sweden and Turkey by HEC.
Dr. Niranjan Koirala received his Ph.D. (2016) in biochemistry (Biochemical engineering), Sun Moon University, Republic of Korea. He has completed assignments as a Postdoctoral research fellow (Microbial-Industrial biotechnology), Universidad Nacional Autonoma de Mexico (QS global world rank-103), under the supervision of Professor Sergio Sanchez (2018) and ongoing Postdoctoral research fellow at the University of Macau (QS global world rank-387), Macau SAR-China at the faculty of science and technology (Environmental-Industrial biotechnology). His interest is in the field of industrial biotechnology, biochemical engineering, pharmaceutical engineering and pharmaceutical/medicinal chemistry. Technically he has skills in genome mining, gene isolation using PCR, cloning and protein purification, metabolic engineering, metabolic co-factor channeling, synthesis using enzyme biocatalysis, bioprocess-fermentation technology, phytochemicals, modifications and testing biological activities, methanogenesis optimization, biogas/biodiesel from waste, UASB reactor, HPLC, ESI-MS, GC-MS, and NMR. His research works collaborate with the American, Mexican, Vietnamese, Chinese, Indian, Iranian, Nepalese and Korean groups till date and its expanding more. He likes to work on research projects producing high-quality publications and patents. Research works he has completed till date have been cited by the International research community (Citation: 400; h-index: 10; i10-index: 11, as indexed by Google Scholar). His works have been published in Internationally reputed indexed journals like Journal of Biotechnology, Journal of Industrial Microbiology and Biotechnology, Enzyme and Microbial Technology, World Journal of Microbiology and Biotechnology, Antonie Van Leeuwenhoek, Applied Biochemistry and Biotechnology to name a few selected ones. Moreover, most of the research works he carried out in the area of secondary metabolites during his Ph.D. study have been granted patents rights by Korean Intellectual Patents Office, Korea. He has been awarded the best poster presentation award and best oral presentation award in the international conferences; Nepal Bidhya Bhushan “A” medal from the honorable President of Nepal; Dean’s Choice award by Sun Moon University, South Korea; BRICPL Young Scientist award by Biologix Research and Innovation Center, India; Shreepati Koirala Memorial Academic Award; Certificate of appreciation by Koirala Welfare Society-Kaski, Nepal to name a few selected ones. He is a member of American Society for Microbiology, International Chemical Biology Society and a lifetime member of Biotechnology Society of Nepal. Professionally, Dr. Koirala has experiences in supervising undergraduate and graduate students of biotechnology and biochemistry majors. He is actively serving in several international journals as an editorial board member and reviewer. Further, he has been invited and participated in several national and international conferences and workshops in the capacity of organizing committee member or a speaker. Presently he is working on his book chapters, article publications and conference organizations.
Dr. Fuhr has 30+ years of experience in teaching and research. He is Professor of Economics at Widener University. Dr. Fuhr’s primary research areas are antitrust, health economics, pharmacoeconomics, telecommunications, and sports economics. He has published over forty journal articles. In health care, he has written on hospital mergers, exclusive arrangements, health insurance, bundling and doctor’s fees. In pharmacoeconomics, Dr. Fuhr has written on cost benefit analysis and predictive modeling. Dr. Fuhr’s primary research areas are antitrust, health economics, pharmacoeconomics, telecommunications, and sports economics.
Dr. M. Rajan obtained his M.Sc., Ph.D. from the Manonmaniam Sundaranar University, Tamil Nadu, India in the subject of Chemistry. He is currently worked as an Assistant Professor at the Department of Natural Products Chemistry, School of Chemistry, Madurai Kamaraj University, Madurai, Tamil Nadu, India. Dr. Rajan's Biomaterials in Medicinal Chemistry laboratory (BMCL) at SOC, MKU, India is mainly interested in the development of biodegradable polymeric nanocarrier systems, nanocomposite scaffolds, bio-ceramic materials and mineral substituted scaffold for Tissue engineering, Drug Delivery and Wound Dressing applications. Dr. Rajan has published more than 90 international publications, three books and five book chapters. Under guidance, three Phd Students were completed and six ongoing. He completed 5 major research projects and two major projects are ongoing from national and international funding agencies.
Howaida I. Abd-Alla, Ph.D., specializes in metabolomics natural products chemistry and completed her Ph.D. at the University of Cairo in 2004. After spending time as a postdoctoral fellow at Laboratoire des Interactions Moléculaires et Réactivité Chimique et Photochimique UMR CNRS 5623, Université de Toulouse, France, she became a professor in the Chemistry of Natural Compounds Department, National Research Centre, Egypt. Currently, Prof. Dr. Abd-Alla works as the head of the Department where her research focuses primarily on isolation, purification and identification of natural compounds from medicinal plants, bacteria and marine organisms using advanced techniques for identification (1D and 2D NMR analysis), synthesis of derivatives of natural products, and bioactive assays in vivo and in vitro in natural products for use in treating different diseases.
Name: Donatas Stakišaitis Address: National Cancer Institute, Santariški? 1, LT-08660 Vilnius, Lithuania E-mail : firstname.lastname@example.org Date of birth: February 24, 1956 Citizenship: Lithuanian Academic qualification: Kaunas Medical University Academic period: 1974–1981 Speciality: physician Employment history - 1981–1985, physician of Regional Central Hospital. - 1985–1988, a post-graduate course at the Post-graduate Medical Department of Vilnius University; also, part-time physician at the Department of Intensive Care (thesis defended for the Ph.D. degree in 1988). - 1988–1992, engaged in research at the Institute of Cardiology, Kaunas Medical University; prepared and defended a thesis (dissertation) for Habil.D. of medicine degree in 1992. - 1992–1994, a researcher at Vilnius University Emergency Hospital; also, a part-time physician at the Department of Anaesthesiology and Intensive Care; - 1994–1996, a research associate at the Department of Medicine of the University of Illinois, Chicago; - 1996–1998, a research associate at the Northwestern University, Chicago (studies performed at this department were selected for an award by Central Society for Clinical Research (09 25 97, Chicago); - 1998–2002, a researcher of Paediatric Center at Vilnius University Medical Faculty; - from 1999 expert at Preclinical and Clinical Trial Division of the State Medicines Control Agency of Lithuania; from 2001 to 2012 – head of Preclinical and Clinical Trial Division of the State Medicines Control Agency of Lithuania (assessing applications and protocols for clinical trials of investigational medicinal products: non-clinical and clinical parts); - from 2002 – researcher of Oncology Institute at Vilnius University; from 2015 – Head researcher. - 2005–2017 Professor at the Mykolas Romeris University, Department of Biolaw, Vilnius. - From 2016 Professor at the Lithuanian University of Health Science, Department of Histology and Embryology